Trebananib Completed Phase 2 Trials for Prostate Neoplasms / Prostatic Neoplams / Prostatic Neoplasms / Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01553188AMG 386 and Abiraterone for Advanced Prostate Cancer